Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

  title={Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010},
  author={Sarah Adler and David A Basketter and Stuart Creton and Olavi Pelkonen and Jan van Benthem and Val{\'e}rie Zuang and Klaus Ejner Andersen and Alexandre Angers-Loustau and Aynur O. Aptula and Anna Bal-Price and Emilio Benfenati and Ulrike Bernauer and Jos Bessems and Fr{\'e}d{\'e}ric Y. Bois and Alan R. Boobis and Esther F. A. Brandon and Susanne Bremer and Thomas H. Broschard and Silvia Casati and Sandra Coecke and Raffaella Corvi and Mark T. D. Cronin and George P. Daston and Wolfgang Dekant and Susan P. Felter and Elise Grignard and Ursula M. Gundert-Remy and Tuula Heinonen and Ian Kimber and Jos Kleinjans and Hannu Komulainen and Reinhard Kreiling and Joachim Kreysa and Sofia B Leite and George D Loizou and G. Maxwell and Paolo Mazzatorta and Sharon Munn and Stefan Pfuhler and Pascal Phrakonkham and Aldert H Piersma and Albrecht Poth and Pilar Prieto and Guillermo Repetto and Vera Maria Rogiers and Greet Schoeters and Michael Schwarz and Rositsa Serafimova and Hanna T{\"a}hti and Emanuela Testai and Joost van Delft and Henk van Loveren and Mathieu Vinken and Andrew Paul Worth and J. M. Zald{\'i}var},
  journal={Archives of Toxicology},
The 7th amendment to the EU Cosmetics Directive prohibits to put animal-tested cosmetics on the market in Europe after 2013. In that context, the European Commission invited stakeholder bodies (industry, non-governmental organisations, EU Member States, and the Commission’s Scientific Committee on Consumer Safety) to identify scientific experts in five toxicological areas, i.e. toxicokinetics, repeated dose toxicity, carcinogenicity, skin sensitisation, and reproductive toxicity for which the… 

A State-of-the-Art Review on the Alternatives to Animal Testing for the Safety Assessment of Cosmetics

It is concluded that educating consumers and inviting them to take part in advocacy could be an effective tool to achieve policy changes, regulatory acceptance, and investment in innovation.

Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies

Current EU regulatory requirements for the human health assessment of chemicals under REACH and the Cosmetic Products Regulation are summarized, considering the more critical endpoints and identifying the main challenges in introducing alternative methods into regulatory testing practice.

Safety Evaluation of Cosmetic Ingredients: In Vitro Opportunities for the Identification of Contact Allergens

This review aims to discuss the state-of-the-art in the field of in vitro assessment of contact sensitizers and predicts that a predictive method to totally replace animal testing will be in the form of a test battery comprising molecular, cell-based, and/or computational methods, the so-called “Integrated Approaches to Testing and Assessment”.

Related Topic: Safety Evaluation and Alternatives to Animal Testing for Skin Toxicity

The need for further international deliberation on the EU directive and on the handling of cosmetic products developed in places where no animal testing continues is strongly felt.

An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".

A group of 17 independent experts from the US, Europe, and Japan was brought together to evaluate the report and strongly endorsed the report, finding greater promise in the short term for the areas of sensitization and toxicokinetics.

Consensus report on the future of animal-free systemic toxicity testing.

A focus on data quality, combined with increased attention to the scientific background of a test method, will be important drivers in the test development process, and quantitative information on all factors and key events will be fed into systems biology models that allow a probabilistic risk assessment with flexible adaptation to exposure scenarios and individual risk factors.

Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?

Europe sticks to replacement methods only for cosmetic testing, and progress made in the practical application of tiered approaches combining in vitro and in vivo methodology, and of read across and weight of evidence strategies is ignored to a major extend.

Continuing Animal Tests on Cosmetic Ingredients for REACH in the EU.

The public should be made aware of REACH testing until the conflict between the regulations is resolved, and the importance to consumers and the cosmetic industry of having cosmetics free of animal testing is made aware.

ECVAM Technical Report on the Status of Alternative Methods for Cosmetics Testing (2008-2009)

The ECVAM technical report presents the progress made in the development and validation of alternative methods for the human health effects relevant to the Cosmetics Directive and intends to present the latest scientific and technical developments in the field during 2008-2009.



How to assess the mutagenic potential of cosmetic products without animal tests?

Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation

The main questions answered in this report are whether it would be possible to give detailed guidance on how to grade allergen potency based on the existing methods, whether such grading could be translated into practical thresholds and whether these could be set for both induction and elicitation.

Making Validated Alternatives Available -the Strategies and Work of the European Centre for the Validation of Alternative Methods (ECVAM)

ECVAM was created in 1991 further to Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes which prescribes to use alternative methods whenever

Safety assessment of personal care products/cosmetics and their ingredients.

Critical analysis of the SCCNFP/SCCP safety assessment of cosmetic ingredients (2000-2006).

Threshold of toxicological concern (TTC) in food safety assessment.

Toxicological comments to the discussion about REACH

Any waiving of repeated dose studies in animals bears the probability of unforeseen effects in case of acute or continuous human exposure, and under the circumstances only two options are available: to reduce very substantially the estimation of hazard and risk with inevitable adverse consequences for human health and environmental protection, or to continue the existing methods until properly validated new methods are available.

The Current Scientific and Legal Status of Alternative Methods to the LD50 Test for Botulinum Neurotoxin Potency Testing

An Expert Meeting on the status of the different alternative methods to the BoNT LD50 potency test that are cited in the European Pharmacopoeia 6.0 was held on 27–28 April 2009, in Berlin, Germany.

The Assessment of Repeated Dose Toxicity In Vitro: A Proposed Approach

TheECVAM workshop on repeated dose toxicity in vitro was held on 15–17 September 2004, at ECVAM in Ispra, Italy, and the main goal was to discuss and evaluate alternative approaches to in vivo repeated doseoxicity testing.

Global QSAR models of skin sensitisers for regulatory purposes

The development of two global QSAR models using two different computational approaches, which contribute to the hybrid model freely available online, offer a robust and reliable method of assessing skin sensitisation for regulatory use.